The influence of psychological therapy on immune system functioning in patients with parkinson disease

Immunological and neurological markers characteristic of parkinson's disease and their response to visualization and suggestion based mind-body therapy: a pilot study

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-BIN-16009354

Enrollment

Unknown

Registered

2016-10-10

Start date

2014-02-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

1:19 days mental training

2:control

Eligibility

Sex/Gender

Male

Age

61 Years to 76 Years

Inclusion criteria

Inclusion criteria: 1) minimum age 60 years; 2) idiopathic PD; 3) Subjects, who have been treated with levodpopa therapy for at least 5 years; 4) Subjects with no dementia or psychiatric abnormalities, free from any other chronic illnesses; 5) Subjects, who have given written informed consent.

Exclusion criteria

Exclusion criteria: 1) Subjects with a history of psychotic illness, dementia or who have major depressive disorder; 2) serve chronic inflammation; 3) bad general health.

Design outcomes

Primary

Measure	Time frame
Immunological markers;neurological markers;motor and cognitive skills;	—

Countries

Poland

Contacts

Public ContactJoanna Ostapiuk-Karolczuk

Department of Physiological Science, Faculty of Physical Education in Gorzow Wlkp. University School of Physical Education Poznan

joanna.ostapiuk@gmail.com+48 9 57279246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026